Post-approval studies (Phase 4)Study completedNCT00520494
What this trial is testing
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
CSL Behring 18